Physician profile
Tracy C Jacobs
NPI 1245498989
$12,792.86
in general payments reported to CMS, 2019-2025
52 companies · $2,810 in 2025
The $2,810 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,445 · 2020: $2,486 · 2021: $1,644 · 2022: $1,407 · 2023: $670 · 2024: $1,330 · 2025: $2,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,810.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,637.38 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $1,138.69 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,032.85 | 2020-2025 | |
| Amgen INC. | $810.31 | 2019-2025 | Repatha, Otezla, Repatha |
| Pfizer INC. | $760.77 | 2019-2025 | |
| Lilly USA, LLC | $610.34 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $490.35 | 2019-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $469.30 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $450.06 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $421.42 | 2019-2025 | Trintellix |
| Allergan, INC. | $392.49 | 2019-2020 | |
| Glaxosmithkline, LLC. | $330.98 | 2020-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $253.50 | 2024-2025 | |
| Kowa Pharmaceuticals America, INC. | $249.98 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $214.49 | 2019-2020 |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Jacobs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.